GPER1 and breast cancer: It is also demonstrated that 17-β-estradiol can bind and activate this receptor and the genes that are activated are those involved in cell proliferation, migration etc. Blocking the GPR30 action using inhibitors such as calicosyn can inhibit proliferation in breast cancer cells (65).